Results for iec protected 4: translation from English to Spanish

iec protected-4-7
iec protegida-4-7

rights are protected 4
los derechos humanos 16 - 31 5

5 x vehicle, apc -- mine protected 4 x 4 springbuck
vehículo blindado de transporte de tropas todoterreno springbuck con protección contra minas

<PROTECTED> qd <PROTECTED> - 4 <PROTECTED>
<PROTECTED> qd <PROTECTED> - 4 <PROTECTED>

<PROTECTED> (4 tx centers)
<PROTECTED> (4 centros tto.)

<PROTECTED>,4 300mg/day
<PROTECTED>,4 300 mg/día

<PROTECTED> 4/s cartoning machine
estuchado <PROTECTED> 4/s

<PROTECTED> 4 points (mg/dl)
<PROTECTED> 4 puntos (mg/dl)

j <PROTECTED> <PROTECTED> 4, 113-121 (2002).
j <PROTECTED> <PROTECTED> 4, 113121 (2002).

operation of the <PROTECTED> 4/s type <PROTECTED> cartoning machine
funcionamiento de la encartonadora <PROTECTED> tipo <PROTECTED> 4/s

previous receipt of anti-<PROTECTED>-4 antibody or cancer vaccine
tratamiento anterior con anticuerpos anti-<PROTECTED>-4 o vacuna contra el cáncer

1 <PROTECTED> et al, <PROTECTED> <PROTECTED> of <PROTECTED> 2003; 3 (<PROTECTED>. 4):
1 <PROTECTED> et al, <PROTECTED> <PROTECTED> of <PROTECTED> 2003; 3 (<PROTECTED>.

<PROTECTED>-4 blockade by <PROTECTED> is independent of <PROTECTED>-a*0201 status2
el bloqueo de <PROTECTED>-4 por acción de <PROTECTED> es independientedel estado <PROTECTED>-a*02012

<PROTECTED>. 4 is a plan view of a segment of a metallic reinforcing structure suitable for use in the present invention.
la <PROTECTED>. 4 es una vista en planta de un segmento de una estructura de refuerzo metálico adecuada para uso en la presente invención.

to assess for the presence of neutralising antibodies, samples from 29 patients with confirmed binding activity to the modified cytotoxic t-lymphocyte-associated antigen 4 (<PROTECTED>-4) region of the molecule were assessed by an in vitro assay; 8 (27.6%) patients were shown to possess neutralising antibodies.
para evaluar la presencia de anticuerpos neutralizantes, se evaluaron muestras de 29 pacientes con actividad confirmada de unión a la región modificada del antígeno 4 asociado al linfocito t citotóxico (<PROTECTED>-4) de la molécula, mediante una prueba in vitro; se demostró que 8 (27,6%) pacientes presentaban anticuerpos neutralizantes.